Clarivate’s Epidemiology’s coverage of the shingles vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France…
Clarivate Epidemiology’s coverage of the Hepatitis B vaccine (HBV) vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United…
Clarivate’s Epidemiology’s coverage of pneumococcal vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States,…
Clarivate’s Epidemiology’s coverage of meningococcal ACWY vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States…
Clarivate’s Epidemiology’s coverage of influenza vaccine comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France,…
The oral type 2 diabetes (T2D) drug market is expected to grow, fueled by rising prevalence and an increasing aging population. Owing to the risk of proteinuria, cardiovascular (CV) complications,…
Acute myeloid leukemia (AML), the most common form of leukemia in adults, is associated with poor five-year overall survival rates. After years of chemotherapy-dominated treatment, the FDA approved…
KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand which drugs to…